top of page
Writer's pictureMark Ziats

The evolving landscape for compounded GLP-1 drugs

A lawsuit from a compounding trade group in October claimed tirzepatide was still in shortage, forcing the FDA to reassess.



FDA says tirzepatide shortage is over after taking a second look



3 views0 comments

Recent Posts

See All

WSJ Article on Stopping Ozempic

Many patients ask me if they have to 'stay on it forever'-- the answer is no but the emerging data suggest their may be some rebound....

WSJ Article on Sleep and Diet

One of the most common compliants I get it sleep related. Interesting article discussing how diet and dietary choices can impact sleep....

Comments


bottom of page